Back to Journals » Drug Design, Development and Therapy » Volume 16

Novel 2-(5-Aryl-4,5-Dihydropyrazol-1-yl)thiazol-4-One as EGFR Inhibitors: Synthesis, Biological Assessment and Molecular Docking Insights

Total article views   HTML views PDF downloads Totals
6,000 Dovepress* 5,846+ 376 6,222
PubMed Central* 154 92 246
Totals 6,000 468 6,468
*Since 16 May 2022

View citations on PubMed and Google Scholar